L-arginine increases ischemic injury in wild-type mice but not in iNOS-deficient mice

Brain Research

Volumn 966, Issue 2, 2003, Pages 308-311

  Zhao, Xueren ^a   Ross, M Elizabeth ^a,b   Iadecola, Costantino ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cerebral ischemia; iNOS null mouse; Middle cerebral artery occlusion; Neuroprotection; Stroke

Indexed keywords

ARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME SUBSTRATE; HYPOTHESIS; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; WILD TYPE;

EID: 0037459801     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)04223-3     Document Type: Article

References (22)

1. Physician Desk Reference. 56th Edition:2002;Montvale, New Jersey. 1410 pp.
2. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:2001;593-615.
3. Barbul A. Physiology and pharmacology of arginine. Moncada S., Higgs E.A. Nitric Oxide From L-arginine: A Bioregulatory System. 1990;317-329 Elsevier, Amsterdam.
4. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19:1999;819-834.
5. Forster C., Clark H.B., Ross M.E., Iadecola C. Inducible nitric oxide synthase expression in human cerebral infarcts. Acta Neuropathol. (Berl.). 97:1999;215-220.
6. Gross S.S., Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57:1995;737-769.
7. Han H.S., Qiao Y., Karabiyikoglu M., Giffard R.G., Yenari M.A. Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation. J. Neurosci. 22:2002;3921-3928.
8. Iadecola C., Alexander M. Cerebral ischemia and inflammation. Curr. Opin. Neurol. 14:2001;89-94.
9. Iadecola C., Zhang F., Casey R., Nagayama M., Ross M.E. Delayed reduction in ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17:1997;9157-9164.
10. Iadecola C., Zhang F., Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268:1995;R286-R292.
11. Kirk R. Experimental Design: Procedures for the Behavioral Sciences. 1982;Brooks/Cole, Monterey, CA. 911 pp.
12. Li G., Regutanan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: An endogenous clonidine-displacing substance in the brain. Science. 263:1994;966-969.
13. Lin T.-N., He Y.Y., Wu G., Khan M., Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 24:1993;117-121.
14. Loihl A.K., Asensio V., Campbell I.L., Murphy S. Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice. Brain Res. 830:1999;155-164.
15. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N., Chen H., Mudgett J.S. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
16. Morgan D.M. Polyamines, arginine and nitric oxide. Biochem. Soc. Trans. 22:1994;879-883.
17. Nagayama M., Niwa K., Nagayama T., Ross M.E., Iadecola C. The cyclooxygenase-2 inhibitor NS-398 ameliorates cerebral ischemic injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene. J. Cereb. Blood Flow Metab. 19:1999;1213-1219.
18. Nathan C., Xie Q.-W. Nitric oxide synthetases: Roles, tolls and controls. Cell. 78:1994;915-918.
19. Parmentier S., Bohme G.A., Lerouet D., Damour D., Stutzmann J.M., Margaill I., Plotkine M. Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br. J. Pharmacol. 127:1999;546-552.
20. Parmentier-Batteur S., Bohme G.A., Lerouet D., Zhou-Ding L., Beray V., Margaill I., Plotkine M. Antisense oligodeoxynucleotide to inducible nitric oxide synthase protects against transient focal cerebral ischemia-induced brain injury. J. Cereb. Blood Flow Metab. 21:2001;15-21.
21. Sugimoto K., Iadecola C. Effects of aminoguanidine on cerebral ischemia in mice: comparison between mice with and without inducible nitric oxide synthase gene. Neurosci. Lett. 331:2002;25-28.
22. Zhang F., Casey R.M., Ross M.E., Iadecola C. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke. 27:1996;317-323.